138 related articles for article (PubMed ID: 29389716)
41. Defining the relationship between patient decisions to undergo breast reconstruction and contralateral prophylactic mastectomy.
Agarwal S; Kidwell KM; Kraft CT; Kozlow JH; Sabel MS; Chung KC; Momoh AO
Plast Reconstr Surg; 2015 Mar; 135(3):661-670. PubMed ID: 25719688
[TBL] [Abstract][Full Text] [Related]
42. Mastectomy patterns, but not rates, are changing in the treatment of early breast cancer. Experience of a single European institution on 2315 consecutive patients.
Fancellu A; Sanna V; Cottu P; Feo CF; Scanu AM; Farina G; Bulla A; Spanu A; Paliogiannis P; Porcu A
Breast; 2018 Jun; 39():1-7. PubMed ID: 29454174
[TBL] [Abstract][Full Text] [Related]
43. Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy.
Huang J; Chagpar A
Am J Surg; 2019 Jul; 218(1):170-174. PubMed ID: 30554666
[TBL] [Abstract][Full Text] [Related]
44. Cost-effectiveness Analysis of Contralateral Prophylactic Mastectomy Compared to Unilateral Mastectomy with Routine Surveillance for Unilateral, Sporadic Breast Cancer.
Keskey RC; LaJoie AS; Sutton BS; Kim IK; Cheadle WG; McMasters KM; Ajkay N
Ann Surg Oncol; 2017 Dec; 24(13):3903-3910. PubMed ID: 29039025
[TBL] [Abstract][Full Text] [Related]
45. Indications for Contralateral Prophylactic Mastectomy: A Consensus Statement Using Modified Delphi Methodology.
Wright FC; Look Hong NJ; Quan ML; Beyfuss K; Temple S; Covelli A; Baxter N; Gagliardi AR
Ann Surg; 2018 Feb; 267(2):271-279. PubMed ID: 28594745
[TBL] [Abstract][Full Text] [Related]
46. ASO Author Reflections: Contralateral Prophylactic Mastectomy-Moving Beyond Sociodemographic Factors.
Oseni TO; Zhang B
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):834-835. PubMed ID: 31673940
[No Abstract] [Full Text] [Related]
47. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
[TBL] [Abstract][Full Text] [Related]
48. What is new in the surgical management and prevention of breast cancer?
Spillane AJ
Med J Aust; 2016 May; 204(8):311-4. PubMed ID: 27125805
[TBL] [Abstract][Full Text] [Related]
49. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
Pinell-White XA; Kolegraff K; Carlson GW
Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
[TBL] [Abstract][Full Text] [Related]
50. A Comparison of Complications in Therapeutic versus Contralateral Prophylactic Mastectomy Reconstruction: A Paired Analysis.
Sergesketter AR; Marks C; Broadwater G; Shammas RL; Greenup RA; Clancy S; Plichta JK; Hollenbeck ST; Phillips BT
Plast Reconstr Surg; 2022 May; 149(5):1037-1047. PubMed ID: 35245238
[TBL] [Abstract][Full Text] [Related]
51. Socioeconomic Factors Associated with the Receipt of Contralateral Prophylactic Mastectomy in Women with Breast Cancer.
Jerome-D'Emilia B; Trinh H
J Womens Health (Larchmt); 2020 Feb; 29(2):220-229. PubMed ID: 30759049
[No Abstract] [Full Text] [Related]
52. Factors contributing to persistent rates of contralateral prophylactic mastectomy in breast cancer patients: Examination of 1051 mastectomies across a single health system.
Bekeny JC; Schreeder CA; Wirth P; Luvisa K; Perez-Alvarez IM; Black CK; Giladi A; Song DH; Willey SC; Fan KL
Breast J; 2020 Dec; 26(12):2341-2349. PubMed ID: 33037675
[TBL] [Abstract][Full Text] [Related]
53. Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer.
Stucky CC; Gray RJ; Wasif N; Dueck AC; Pockaj BA
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():330-7. PubMed ID: 20853055
[TBL] [Abstract][Full Text] [Related]
54. Bilateral immediate two-stage breast reconstruction in patients with unilateral breast cancer: Outcomes analysis and risk assessment.
Ozturk CN; Ozturk C; Soucise A; Ahsan N; Kuhn J; Platek M; Lohman R; Moon W; Gurunian R
J Plast Reconstr Aesthet Surg; 2021 Mar; 74(3):480-485. PubMed ID: 33069605
[TBL] [Abstract][Full Text] [Related]
55. Why women with an average risk for breast cancer undergo contralateral breast mastectomy? Does healthcare coverage matter?
Masood S
Breast J; 2021 Oct; 27(10):743-745. PubMed ID: 34582066
[No Abstract] [Full Text] [Related]
56. Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.
Jakub JW; Peled AW; Gray RJ; Greenup RA; Kiluk JV; Sacchini V; McLaughlin SA; Tchou JC; Vierkant RA; Degnim AC; Willey S
JAMA Surg; 2018 Feb; 153(2):123-129. PubMed ID: 28903167
[TBL] [Abstract][Full Text] [Related]
57. Contralateral prophylactic mastectomy: What should not be forgotten to improve communication between clinicians and patients!
Franceschini G; Di Leone A; Masetti R
Patient Educ Couns; 2019 Aug; 102(8):1573-1574. PubMed ID: 30905494
[No Abstract] [Full Text] [Related]
58. The effect of contralateral prophylactic mastectomy on breast-related charges: A 5-year analysis.
Smith JR; Jaffe J; Pruitt J; Yao K; Sisco M; Kuchta K; Wang CE; Howard MA
J Surg Oncol; 2018 Jul; 118(1):212-220. PubMed ID: 30098307
[TBL] [Abstract][Full Text] [Related]
59. Contralateral prophylactic mastectomy in women with breast cancer without a family history or genetic predisposition : Consensus statement from the Austrian Gynecologic Oncology Working Group of the Austrian Society of Obstetrics and Gynecology.
Bjelic-Radisic V; Singer C; Tamussino K; Kölbl H; Petru E; Volgger B; Polterauer S; Oppelt P; Sevelda P; Bogner G; Marth C;
Wien Klin Wochenschr; 2019 May; 131(9-10):233-236. PubMed ID: 30887224
[TBL] [Abstract][Full Text] [Related]
60. Bilateral Mastectomy versus Breast-Conserving Surgery for Early-Stage Breast Cancer: The Role of Breast Reconstruction.
Albornoz CR; Matros E; Lee CN; Hudis CA; Pusic AL; Elkin E; Bach PB; Cordeiro PG; Morrow M
Plast Reconstr Surg; 2015 Jun; 135(6):1518-1526. PubMed ID: 26017588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
